Kamil Piska

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Methicillin Resistant Staphylococcus Aureus

Candida Albicans

Top Venues

ACS medicinal chemistry letters

Molecules (Basel, Switzerland)

Cancer chemotherapy and pharmacology

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Vittorio Canale, Iwona Skiba-Kurek, Karolina Klesiewicz, Monika Papież, Marlena Ropek, Bartosz Pomierny, Kamil Piska, Paulina Koczurkiewicz, Joanna Empel, Elżbieta Karczewska, Paweł Zajdel
Improving Activity of New Arylurea Agents against Multidrug-Resistant and Biofilm-Producing Staphylococcus epidermidis . ACS medicinal chemistry letters 15 (3) (2024)
Vittorio Canale, Iwona Skiba-Kurek, Karolina Klesiewicz, Monika Papież, Marlena Ropek, Bartosz Pomierny, Kamil Piska, Paulina Koczurkiewicz, Joanna Empel, Elżbieta Karczewska, Paweł Zajdel
Improving Activity of New Arylurea Agents against Multidrug-Resistant and Biofilm-Producing Staphylococcus epidermidis . ACS medicinal chemistry letters 15 (3) (2024)
Aleksandra Murzyn, Justyna Orzeł, Natalia Obajtek, Anna Mróz, Dominika Miodowska, Patrycja Bojdo, Bartosz Gąsiorkiewicz, Paulina Koczurkiewicz-Adamczyk, Kamil Piska, Elżbieta Pękala
Aclarubicin: contemporary insights into its mechanism of action, toxicity, pharmacokinetics, and clinical standing. Cancer chemotherapy and pharmacology (2024)
Marek Jamrozik, Kamil Piska, Adam Bucki, Paulina Koczurkiewicz, Michał Sapa, Benedykt Władyka, Elżbieta Pękala, Marcin Kołaczkowski
In Silico and In Vitro Assessment of Carbonyl Reductase 1 Inhibition Using ASP9521-A Potent Aldo-Keto Reductase 1C3 Inhibitor with the Potential to Support Anticancer Therapy Using Anthracycline Antibiotics. Molecules (Basel, Switzerland) 28 (9) (2023)
Marek Jamrozik, Kamil Piska, Adam Bucki, Paulina Koczurkiewicz, Michał Sapa, Benedykt Władyka, Elżbieta Pękala, Marcin Kołaczkowski
In Silico and In Vitro Assessment of Carbonyl Reductase 1 Inhibition Using ASP9521-A Potent Aldo-Keto Reductase 1C3 Inhibitor with the Potential to Support Anticancer Therapy Using Anthracycline Antibiotics. Molecules (Basel, Switzerland) 28 (9) (2023)
Paulina Koczurkiewicz, Karolina Grabowska, Elżbieta Karnas, Kamil Piska, Dawid Wnuk, Katarzyna Klas, Agnieszka Galanty, Katarzyna Wójcik-Pszczoła, Marta Michalik, Elżbieta Pękala, Hendrik Fuchs, Irma Podolak
Saponin Fraction CIL1 from Lysimachia ciliata L. Enhances the Effect of a Targeted Toxin on Cancer Cells. Pharmaceutics 15 (5) (2023)
Paulina Koczurkiewicz-Adamczyk, Katarzyna Klaś, Agnieszka Gunia-Krzyżak, Kamil Piska, Kalina Andrysiak, Jacek Stępniewski, Sławomir Lasota, Katarzyna Wójcik-Pszczoła, Jozef Dulak, Zbigniew Madeja, Elżbieta Pękala
Cinnamic Acid Derivatives as Cardioprotective Agents against Oxidative and Structural Damage Induced by Doxorubicin. International journal of molecular sciences 22 (12) (2021)
Bartosz Mateusz Gąsiorkiewicz, Paulina Koczurkiewicz, Kamil Piska, Elżbieta Pękala
Autophagy modulating agents as chemosensitizers for cisplatin therapy in cancer. Investigational new drugs 39 (2) (2020)